The BET-Bromodomain Inhibitor JQ1 Reduces Inflammation and Tau Phosphorylation at Ser396 in the Brain of the 3xTg Model of Alzheimer’s Disease

The BET-Bromodomain Inhibitor JQ1 Reduces Inflammation and Tau Phosphorylation at Ser396 in the Brain of the 3xTg Model of Alzheimer’s Disease

Alzheimer’s disease (AD) is a progressive neurodegenerative disease characterized by well-defined neuropathological brain changes including amyloid plaques, neurofibrillary tangles and the presence of chronic neuroinflammation. Objective: The brain penetrant BET bromodomain inhibitor JQ1 has been sh...

Full description

Bibliographic Details
Main Authors: Magistri, Marco, Velmeshev, Dmitry, Makhmutova, Madina, Patel, Prutha, Sartor, Gregory C., Volmar, Claude-Henry, Wahlestedt, Claes, Faghihi, Mohammad Ali
Format: Online
Language:English
Published: Bentham Science Publishers 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026248/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026248/

Similar Items